SCHEMBL31276010

SCHEMBL31276010

C#Cc1cc(C(C)(C)C#N)ncn1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004152 0.81 HDAC8 (0.31) HDAC8
SCHEMBL17808311 0.77 CYP19A1 (0.32) —
SCHEMBL16454359 0.76 CYP19A1 (0.31) —
SCHEMBL20927051 0.75 — —
SCHEMBL18857405 0.75 — —
SCHEMBL16447062 0.74 AAK1 (0.32) —
SCHEMBL18948788 0.72 — —
SCHEMBL19069179 0.72 — —
SCHEMBL18699160 0.71 CYP3A4 (0.31) —
SCHEMBL19190828 0.71 CYP1A2 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4720036-A1 CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF 16380026 Canada Inc. (CA) 2026-04-08 — — EP disclosed
WO-2024243692-A1 CYP26B1 INHIBITOR COMPOUNDS AND METHODS OF USE THEREOF QUEEN'S UNIVERSITY AT KINGSTON (CA) 2024-12-05 — — WO disclosed
Send feedback